Richard L. Jackson

Richard L. Jackson discloses dealings in Cascadian Therapeutics, Inc. to SEC (Form 4). Between 12 February 2008 and 13 June 2015, the trades on record add up to 19 filings.

The open-market record is one-sided, with 1 purchase worth €8,915 and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 12 share grants and 6 option exercises.

On 16 June 2015 came the latest disclosure, a share grant for €14k in Cascadian Therapeutics, Inc. The latest purchase dates back some time: it was published 6,843 days ago, on 14 February 2008. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.